Brief: Sensorion and Novasep Sign Gene Therapy Product Development and Manufacturing Agreement

Sensorion SA

27/10/2020 06:34

Oct 27 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION AND NOVASEP ANNOUNCE SIGNATURE OF A GENE THERAPY
PRODUCT DEVELOPMENT AND MANUFACTURING AGREEMENT
    * AGREEMENT COVERS DEVELOPMENT AND MANUFACTURING OF AAV
VECTORS, A
KEY STEP FOR SENSORION'S GENE THERAPY PROGRAMS
    * AGREEMENT SECURES DRUG PRODUCT DEVELOPMENT AND
MANUFACTURING
CAPACITY FOR COMPANY'S OTOFERLIN PROGRAM
    * GENE THERAPY COULD REVOLUTIONIZE TREATMENT OF GENETIC
INNER EAR
DISORDERS
    * AGREEMENT SECURES DRUG PRODUCT DEVELOPMENT AND
MANUFACTURING
CAPACITY FOR THE COMPANY’S OTOFERLIN PROGRAM

Source text for Eikon:  ID:nBw420dYla 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))